Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2025

Aug 6, 2025

32853_dirs_2025-08-05_c98c4771-2285-4873-9e89-9d35b4802655.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2025-08-01

Reporting Person: Kim Hanjoon Alex (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-08-01 Common Stock A 1500000 Acquired 2440564 Direct

Footnotes

F1: Represents Restricted Stock Units ("RSUs") that vest as to 40% of the RSUs on July 20, 2026, with the remaining 60% of the RSUs vesting on July 20, 2027, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting.

F2: Includes an aggregate of 12,861 shares of common stock previously acquired by the Reporting Person under the Issuer's Employee Stock Purchase Plan.